This is not a simple “same specification, lower price” comparison. HM-BV-30 uses TVAPS terminology; Lumis 150 uses iVAPS. Both sit in the volume-assured bilevel category, but the algorithms are not interchangeable and the clinician must translate the prescription.
| Factor | HM-BV-30 | ResMed Lumis 150 |
|---|---|---|
| Indicative price | About ₹38,000 | About ₹63,490 |
| Published modes | CPAP, APAP, S, Auto S, ST, T, TVAPS | Includes S, ST, T and iVAPS-class therapy by SKU |
| Pressure ceiling | Up to 30 cmH₂O | Confirm exact Indian SKU |
| Reporting | Memory card + Claro on Windows/macOS | ResScan/AirView ecosystem by configuration |
| Best fit | Value-focused clinician-supported TVAPS | Premium iVAPS and connected clinical workflow |
Where HM-BV-30 wins
Value: it delivers a broad mode stack and a 4–30 cmH₂O published pressure range at roughly ₹25,000 less.
Offline clinical detail: Claro provides summaries, trends, waveforms, events, pressure, leak, airflow, and AHI views from the memory card on Windows or macOS. That supports periodic review without locking the patient to a cloud platform.
Warranty positioning: the three-year/10,000-hour published warranty and India-side brand position can be attractive where Home Medix has responsive service.
HM-BV-30 is compelling for a cost-limited home NIV patient whose treating team has reviewed the TVAPS controls and can titrate the device directly.
Where Lumis 150 wins
iVAPS ecosystem: Lumis 150 is the correct choice when the clinician has prescribed or standardised on ResMed iVAPS rather than a generic volume target.
Clinical familiarity and data: ResMed’s ventilation platform, software, accessories, and service documentation are familiar to many sleep and respiratory teams. Connected configurations can simplify remote follow-up.
Premium support footprint: for complex neuromuscular, hypoventilation, or overlap cases, a mature device-specific clinical workflow can justify the higher price.
What must match before switching
Do not map these machines using “target volume” alone. The clinician should verify:
- IPAP/EPAP range and maximum pressure support.
- Backup-rate behaviour and timed inspiration controls.
- How target ventilation or volume is calculated and adjusted.
- Trigger, cycle, rise-time, leak compensation, and alarm behaviour.
- Mask type, humidification, supplemental-oxygen connection, and report availability.
Read TVAPS, AVAPS, and iVAPS devices in India before treating the terms as equivalents.
Verdict
HM-BV-30 is the stronger commercial-value choice when its TVAPS mode fits the clinician’s plan and local service is adequate. Lumis 150 is the stronger clinical-platform choice when iVAPS, ResMed’s ecosystem, or connected specialist follow-up is load-bearing. For complex ventilation, the cheapest compatible-looking machine is not necessarily compatible.